Search results for hip
Bisphosphonate therapy associated with fewer vertebral fractures in men
Two annual injections of zoledronic acid reduced risk of vertebral fracture among men with osteoporosis, according to a study supported by the drug's manufacturer.
https://immattersacp.org/weekly/archives/2012/11/06/4.htm
6 Nov 2012
Stroke risk may be higher up to 12 weeks after hip replacement, study finds
Risk for stroke is elevated up to 12 weeks after total hip replacement, according to a new study.
https://immattersacp.org/weekly/archives/2012/11/13/5.htm
13 Nov 2012
Patients may overestimate benefits of screening programs, preventive medicines
Patients overestimated the risk reduction achieved with screening and preventive medications, and clinicians should keep that tendency in mind when discussing such issues with patients, a study found.
https://immattersacp.org/weekly/archives/2012/11/20/5.htm
20 Nov 2012
Expanded approval on rivaroxaban, reassurance on dabigatran
This regulatory update covers an expanded indication for rivaroxaban and an announcement that bleeding rates do not appear to be higher with dabigatran than with warfarin.
https://immattersacp.org/archives/2013/01/fda.htm
1 Jan 2013
Task Force advises against vitamin D, calcium for primary prevention of fractures in postmenopausal women
The U.S. Preventive Services Task Force recommended against taking daily supplementation of 400 IU or less of vitamin D3 and 1,000 mg or less of calcium for the primary prevention of fractures in community-dwelling postmenopausal women.
https://immattersacp.org/weekly/archives/2013/02/26/1.htm
26 Feb 2013
GERD guidelines establish diagnosis, management options
The American Gastroenterological Society issued guidelines for the diagnosis and management of gastroesophageal reflux disease (GERD).
https://immattersacp.org/weekly/archives/2013/03/12/1.htm
12 Mar 2013
Zolpidem dose for women lowered, diabetes drug approved
This regulatory update covers warnings to lower zolpidem doses in women and approvals for a new drug to improve blood glucose control in adults with type 2 diabetes.
https://immattersacp.org/archives/2013/04/fda.htm
1 Apr 2013
Early interventions overlooked in OA
Osteoarthritis has been somewhat neglected, according to a recently formed consortium that is advocating for more proactive diagnosis and intervention. Earlier screening and a less reactive approach might head off some of the worst of the difficulties and related treatment costs.
https://immattersacp.org/archives/2013/05/osteoarthritis.htm
1 May 2013
How to start and stop bisphosphonates
A new online tool and a few simple rules can inform internists how to start bisphosphonates and when to consider taking a drug holiday at the request of another physician, a dentist or even the patient.
https://immattersacp.org/archives/2013/06/bisphosphonates.htm
1 Jun 2013
Aspirin may be noninferior to dalteparin for VTE prophylaxis following hip replacements
Aspirin therapy for 28 days may be a reasonable alternative to low-molecular-weight heparin for extended venous thromboembolism (VTE) prophylaxis among hip replacement patients who have already received low-molecular-weight heparin for 10 days, a study found.
https://immattersacp.org/weekly/archives/2013/06/04/5.htm
4 Jun 2013